Citations (145)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Jing Wang, Christian Karime, Umair Majeed, Jason S. Starr, Mitesh J. Borad & Hani M. Babiker. (2023) Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert Opinion on Investigational Drugs 32:5, pages 387-399.
Read now
Read now
Ruibing Su, Lijun Cai, Pan Xiong, Zhiwei Liu, Shaobin Chen, Xi Liu, Runhua Lin, Zhijin Lei, Dongping Tian & Min Su. (2022) TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. Journal of Inflammation Research 15, pages 1437-1456.
Read now
Read now
Christian Karime, Jing Wang, Gregory Woodhead, Kabir Mody, Charles T. Hennemeyer, Mitesh J. Borad, Daruka Mahadevan, Sreenivasa R. Chandana & Hani Babiker. (2022) Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma. Expert Opinion on Investigational Drugs 31:1, pages 1-13.
Read now
Read now
Zenghua Deng, Mengmeng Xiao, Dexiao Du, Nan Luo, Dongfang Liu, Tingting Liu, Dongbo Lian & Jirun Peng. (2021) DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer. OncoTargets and Therapy 14, pages 2003-2017.
Read now
Read now
Yan Zhao, Huan Wang, Yang Yang, Wendan Jia, Tong Su, Yuxin Che, Yixin Feng, Xuemei Yuan & Xuelian Wang. (2020) Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. International Journal of Nanomedicine 15, pages 9571-9586.
Read now
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Read now
Yan Tie, Hui Yang, Rui Zhao, Heng Zheng, Daoke Yang, Jingyi Zhao & Ming Liu. (2019) Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis. Drug Design, Development and Therapy 13, pages 523-538.
Read now
Read now
Matthew J. Atherton, Kyle B. Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K. Nikota, Hwan Hee Son, Anna Jirovec, Charles Lefebvre, Anna Dvorkin-Gheva, Ali A. Ashkar, Yonghong Wan, David F. Stojdl, Eric C. Belanger, Rodney H. Breau, John C. Bell, Fred Saad, Sheila K. Singh, Jean-Simone Diallo & Brian D. Lichty. (2018) Transforming the prostatic tumor microenvironment with oncolytic virotherapy. OncoImmunology 7:7.
Read now
Read now
Songyang Wu, Hongyong He, Hao Liu, Yifan Cao, Rochen Li, Heng Zhang, He Li, Zhenbin Shen, Jing Qin & Jiejie Xu. (2018) C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer. OncoImmunology 7:6.
Read now
Read now
Qiu Xia, Fei Geng, Fang-Fang Zhang, Chen-Lu Liu, Ping Xu, Zhen-Zhen Lu, Yu Xie, Bo Sun, Hui Wu, Bin Yu, Wei Kong, Xiang-Hui Yu & Hai-Hong Zhang. (2017) Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. Immunopharmacology and Immunotoxicology 39:1, pages 37-44.
Read now
Read now
Laure Aurelian. (2016) Oncolytic viruses as immunotherapy: progress and remaining challenges. OncoTargets and Therapy 9, pages 2627-2637.
Read now
Read now
Roberta Melchionna, Pierluigi Iapicca, Francesca Di Modugno, Paola Trono, Isabella Sperduti, Matteo Fassan, Ivana Cataldo, Borislav C. Rusev, Rita T. Lawlor, Maria Grazia Diodoro, Michele Milella, Gian Luca Grazi, Mina J. Bissell, Aldo Scarpa & Paola Nisticò. (2016) The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome. OncoImmunology 5:12.
Read now
Read now
Gulden Menderes, Christopher Hicks, Jonathan D. Black, Carlton L. Schwab & Alessandro D. Santin. (2016) Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers. Expert Opinion on Biological Therapy 16:8, pages 989-1004.
Read now
Read now
Matthias Braun, Marie L. Ress, Young-Eun Yoo, Claus J. Scholz, Matthias Eyrich, Paul G. Schlegel & Matthias Wölfl. (2016) IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing. OncoImmunology 5:7.
Read now
Read now
Jian Qiao, Mahua Dey, Alan L Chang, Julius W Kim, Jason Miska, Alex Ling, Dirk M Nettlebeck, Yu Han, Lingjiao Zhang & Maciej S Lesniak. (2015) Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy. OncoImmunology 4:8.
Read now
Read now
Tanja D de Gruijl, Axel B Janssen & Victor W van Beusechem. (2015) Arming oncolytic viruses to leverage antitumor immunity. Expert Opinion on Biological Therapy 15:7, pages 959-971.
Read now
Read now
Christel Devaud, Jennifer A Westwood, Michele WL Teng, Liza B John, Carmen SM Yong, Connie PM Duong, Mark J Smyth, Phillip K Darcy & Michael H Kershaw. (2014) Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors. OncoImmunology 3:11.
Read now
Read now
Sarah K Maenhout, Kris Thielemans & Joeri L Aerts. (2014) Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells . OncoImmunology 3:10.
Read now
Read now
Jennifer A Westwood, Phillip K Darcy & Michael H Kershaw. (2014) The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy. OncoImmunology 3:7.
Read now
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch:. OncoImmunology 3:6.
Read now
Read now
Arthur E Frankel. (2013) Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity. Clinical Pharmacology: Advances and Applications 5:sup1, pages 1-3.
Read now
Read now
Giovanna Bossi, Andrew B Gerry, Samantha J Paston, Deborah H Sutton, Namir J Hassan & Bent K Jakobsen. (2013) Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells. OncoImmunology 2:11.
Read now
Read now
Articles from other publishers (123)
Lichun Cheng, Jiankun Yu, Tangna Hao, Wenshuo Wang, Minjie Wei & Guiru Li. (2023) Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment. Pharmaceutics 15:11, pages 2622.
Crossref
Crossref
Alissa J. Cooper & Rebecca S. Heist. (2023) New Therapies on the Horizon. Hematology/Oncology Clinics of North America 37:3, pages 623-658.
Crossref
Crossref
Sevda Jafari, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam & Ommoleila Molavi. (2022) Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. BioImpacts 13:1, pages 51-61.
Crossref
Crossref
Bharati Mehani, Saleembhasha Asanigari, Hye-Jung Chung, Karen Dazelle, Arashdeep Singh, Sridhar Hannenhalli & Kenneth Aldape. (2022) Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology. Acta Neuropathologica Communications 10:1.
Crossref
Crossref
Peiman Norouzi, Maryam Mirmohammadi & Mohammad Hassan Houshdar Tehrani. (2022) Anticancer peptides mechanisms, simple and complex. Chemico-Biological Interactions 368, pages 110194.
Crossref
Crossref
Yan Sun, Hongping Li, Zhiming Ma, Jianfei Wang, Huiyu Yang, Xiaopeng Zhang & Bingrong Liu. (2022) Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer. PLOS ONE 17:11, pages e0278114.
Crossref
Crossref
Pradip Bajgain, Alejandro G. Torres Chavez, Kishore Balasubramanian, Lindsey Fleckenstein, Premal Lulla, Helen E. Heslop, Juan Vera & Ann M. Leen. (2022) Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand–Expressing Solid Tumors. Cancer Immunology Research 10:11, pages 1370-1385.
Crossref
Crossref
Michal Sobecki, Jing Chen, Ewelina Krzywinska, Shunmugam Nagarajan, Zheng Fan, Eric Nelius, Josep M. Monné Rodriguez, Frauke Seehusen, Amro Hussein, Greta Moschini, Edries Y. Hajam, Ravi Kiran, Dagmar Gotthardt, Julien Debbache, Cécile Badoual, Tatsuyuki Sato, Takayuki Isagawa, Norihiko Takeda, Corinne Tanchot, Eric Tartour, Achim Weber, Sabine Werner, Johannes Loffing, Lukas Sommer, Veronika Sexl, Christian Münz, Carol Feghali-Bostwick, Elena Pachera, Oliver Distler, Jess Snedeker, Colin Jamora & Christian Stockmann. (2022) Vaccination-based immunotherapy to target profibrotic cells in liver and lung. Cell Stem Cell 29:10, pages 1459-1474.e9.
Crossref
Crossref
Atefeh Parchebafi, Farzaneh Tamanaee, Hassan Ehteram, Ejaz Ahmad, Hossein Nikzad & Hamed Haddad Kashani. (2022) The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures. Microbial Cell Factories 21:1.
Crossref
Crossref
Melissa Johnson, Arkadiusz Z. Dudek, Ammar Sukari, Justin Call, Paul R. Kunk, Karl Lewis, Justin F. Gainor, John Sarantopoulos, Patrice Lee, Adele Golden, Allison Harney, S. Michael Rothenberg, Yuanyuan Zhang & Jonathan W. Goldman. (2022) ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study. Clinical Cancer Research 28:12, pages 2517-2526.
Crossref
Crossref
Xiangjie Sun, Jie Zhai, Baohua Sun, Edwin Roger Parra, Mei Jiang, Wencai Ma, Jing Wang, Anthony M. Kang, Kasthuri Kannan, Renganayaki Pandurengan, Shanyu Zhang, Luisa Maren Solis, Cara L. Haymaker, Maria Gabriela Raso, Julia Mendoza Perez, Aysegul A. Sahin, Ignacio I. Wistuba, Clinton Yam, Jennifer K. Litton & Fei Yang. (2022) Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer. Modern Pathology 35:5, pages 601-608.
Crossref
Crossref
Antonio Passaro, Julie Brahmer, Scott Antonia, Tony Mok & Solange Peters. (2022) Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. Journal of Clinical Oncology 40:6, pages 598-610.
Crossref
Crossref
Kritika Srinivasan Rajsri & Mana Rao. (2022) Poxvirus-driven human diseases and emerging therapeutics. Therapeutic Advances in Infectious Disease 9, pages 204993612211367.
Crossref
Crossref
Katarzyna Uchimiak, Anna M. Badowska-Kozakiewicz, Aleksandra Sobiborowicz-Sadowska & Andrzej Deptała. (2022) Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges. Clinical Medicine Insights: Oncology 16, pages 117955492210998.
Crossref
Crossref
Neha N. Parayath. 2022. Polymeric Micelles for Drug Delivery. Polymeric Micelles for Drug Delivery
175
197
.
Pankaj Ahluwalia, Ashis K Mondal, Nikhil S Sahajpal, Mumtaz V Rojiani & Ravindra Kolhe. (2021) Gene signatures with therapeutic value: emerging perspective for personalized immunotherapy in renal cancer. Immunotherapy 13:18, pages 1535-1547.
Crossref
Crossref
Francesco Missale, Mattia Bugatti, Davide Mattavelli, Silvia Lonardi, Davide Lombardi, Piero Nicolai, Cesare Piazza, Simonetta Battocchio, Anna Maria Bozzola, Stefano Calza & William Vermi. (2021) Metavariables Resuming Host Immune Features and Nodal Involvement Are Associated with Oncological Outcomes in Oral Cavity Squamous Cell Carcinoma. Cells 10:9, pages 2203.
Crossref
Crossref
Elisavet Vlachonikola, Kostas Stamatopoulos & Anastasia Chatzidimitriou. (2021) T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia. Cancers 13:13, pages 3255.
Crossref
Crossref
Babalola Benjamin A, Adebami Gboyega E & Akinsuyi Samuel E. (2021) Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology. Global Journal of Cancer Therapy, pages 035-042.
Crossref
Crossref
Nayara Gusmão Tessarollo, Ana Carolina M. Domingues, Fernanda Antunes, Jean Carlos dos Santos da Luz, Otavio Augusto Rodrigues, Otto Luiz Dutra Cerqueira & Bryan E. Strauss. (2021) Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy. Cancers 13:8, pages 1863.
Crossref
Crossref
Ava M. Vargason, Aaron C. Anselmo & Samir Mitragotri. (2021) The evolution of commercial drug delivery technologies. Nature Biomedical Engineering 5:9, pages 951-967.
Crossref
Crossref
Szu-Yuan Wu, Kuan-Chou Lin, Bashir Lawal, Alexander T.H Wu & Ching-Zong Wu. (2021) MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Computational and Structural Biotechnology Journal 19, pages 4970-4983.
Crossref
Crossref
Hiroshi Yagi & Kiyoko Kato. 2021. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Molecular Diagnosis and Targeting for Gynecologic Malignancy
57
70
.
Daehyun Kim, Seung Soo Lee, Hyungwon Moon, So Yeon Park & Hak Jong Lee. (2020) PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models. Pharmaceuticals 14:1, pages 6.
Crossref
Crossref
Nora Möhn, Susann Mahjoub, Ralf Gutzmer, Imke Satzger, Gernot Beutel, Philipp Ivanyi, Heiko Golpon, Mike P. Wattjes, Martin Stangel & Thomas Skripuletz. (2020) Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. Journal of Oncology 2020, pages 1-9.
Crossref
Crossref
Nadia Arang & J. Silvio Gutkind. (2020) G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers. FEBS Letters 594:24, pages 4201-4232.
Crossref
Crossref
Xubin Dong, Dian-Na Gu, Ouchen Wang & Zhiqiang Ye. (2020) LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment. International Immunopharmacology 87, pages 106793.
Crossref
Crossref
Robert A. Belderbos, Heleen Vroman & Joachim G. J. V. Aerts. (2020) Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma. Frontiers in Oncology 10.
Crossref
Crossref
Sevda Jafari, Afsaneh Lavasanifar, Mohammad Saied Hejazi, Nasrin Maleki-Dizaji, Mehran Mesgari & Ommoleila Molavi. (2020) STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells. DARU Journal of Pharmaceutical Sciences 28:1, pages 159-169.
Crossref
Crossref
Rachael M. Zemek, Vanessa S. Fear, Cath Forbes, Emma de Jong, Thomas H. Casey, Louis Boon, Timo Lassmann, Anthony Bosco, Michael J. Millward, Anna K. Nowak, Richard A. Lake & W. Joost Lesterhuis. (2020) Bilateral murine tumor models for characterizing the response to immune checkpoint blockade. Nature Protocols 15:5, pages 1628-1648.
Crossref
Crossref
Shweta Joshi, Kevin X. Liu, Muamera Zulcic, Alok R. Singh, Dylan Skola, Christopher K. Glass, P. Dominick Sanders, Andrew B. Sharabi, Timothy V. Pham, Pablo Tamayo, Daniel Shiang, Huy Q. Dinh, Catherine C. Hedrick, Guillermo A. Morales, Joseph R. Garlich & Donald L. Durden. (2020) Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression. Molecular Cancer Therapeutics 19:3, pages 755-764.
Crossref
Crossref
Gadi Cohen, Parwathy Chandran, Rebecca M. Lorsung, Lauren E. Tomlinson, Maggie Sundby, Scott R. Burks & Joseph A. Frank. (2020) The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers 12:2, pages 350.
Crossref
Crossref
Takahiro Wakasaki, Ryuji Yasumatsu, Ryutaro Uchi, Masahiko Taura, Mioko Matsuo, Noritaka Komune & Takashi Nakagawa. (2020) Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma. Auris Nasus Larynx 47:1, pages 116-122.
Crossref
Crossref
Edwin Roger Parra, Mei Jiang, Luisa Solis, Barbara Mino, Caddie Laberiano, Sharia Hernandez, Swati Gite, Anuj Verma, Michael Tetzlaff, Cara Haymaker, Auriole Tamegnon, Jaime Rodriguez-Canales, Clifford Hoyd, Chantale Bernachez & Ignacio Wistuba. (2020) Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies. Cancers 12:2, pages 255.
Crossref
Crossref
D.E. Magee, A.E. Hird, Z. Klaassen, S.S. Sridhar, R.K. Nam, C.J.D. Wallis & G.S. Kulkarni. (2020) Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials. Annals of Oncology 31:1, pages 50-60.
Crossref
Crossref
Victoria H. Wu & J. Silvio Gutkind. 2020. Improving the Therapeutic Ratio in Head and Neck Cancer. Improving the Therapeutic Ratio in Head and Neck Cancer
317
334
.
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, Esther Giehl, Mathilde Feist, Enyong Dai, Weilin Liu, Walter J. Storkus, Yukai He, Zuqiang Liu & David L. Bartlett. (2019) Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
T. Alissafi, A. Hatzioannou, A.I. Legaki, A. Varveri & Panayotis Verginis. (2019) Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells. Journal of Autoimmunity 104, pages 102310.
Crossref
Crossref
C.G. Da Silva, M.G.M. Camps, T.M.W.Y. Li, A.B. Chan, F. Ossendorp & L.J. Cruz. (2019) Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines. Biomaterials 220, pages 119417.
Crossref
Crossref
Yanan Liu, Yayu Wen, Xu Chen, Xufeng Zhu, Qianqian Yu, Youcong Gong, Guanglong Yuan, Jie Liu & Xiuying Qin. (2019) Inflammation-responsive functional Ru nanoparticles combining a tumor-associated macrophage repolarization strategy with phototherapy for colorectal cancer therapy. Journal of Materials Chemistry B 7:40, pages 6210-6223.
Crossref
Crossref
Longlong Tian, Yaxing Wang, Lele Sun, Jun Xu, Yu Chao, Kai Yang, Shuao Wang & Zhuang Liu. (2019) Cerenkov Luminescence-Induced NO Release from 32P-Labeled ZnFe(CN)5NO Nanosheets to Enhance Radioisotope-Immunotherapy. Matter 1:4, pages 1061-1076.
Crossref
Crossref
Yahima Frión-Herrera, Daniela Gabbia, Osmany Cuesta-Rubio, Sara De Martin & Maria Carrara. (2019) Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells. Life Sciences 235, pages 116817.
Crossref
Crossref
Thomas J. George, Aaron J. Franke, A. Bapsi Chakravarthy, Prajnan Das, Arvind Dasari, Bassel F. El‐Rayes, Theodore S. Hong, Timothy J. Kinsella, Jerome C. Landry, James J. Lee, Arta M. Monjazeb, Samuel A. Jacobs, David Raben, Osama E. Rahma, Terence M. Williams, Christina Wu, C. Norman Coleman, Bhadrasain Vikram & Mansoor M. Ahmed. (2019) National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer 125:16, pages 2732-2746.
Crossref
Crossref
Xiaowei Chi, Peiwei Yang, Erhao Zhang, Jieyi Gu, Hui Xu, Mengwei Li, Xinmei Gao, Xin Li, Yinan Zhang, Hanmei Xu & Jialiang Hu. (2019) Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12. Cancer Medicine 8:10, pages 4753-4765.
Crossref
Crossref
Anne Geller, Rejeena Shrestha & Jun Yan. (2019) Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic. International Journal of Molecular Sciences 20:15, pages 3618.
Crossref
Crossref
Victoria Wu, Huwate Yeerna, Nijiro Nohata, Joshua Chiou, Olivier Harismendy, Francesco Raimondi, Asuka Inoue, Robert B. Russell, Pablo Tamayo & J. Silvio Gutkind. (2019) Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. Journal of Biological Chemistry 294:29, pages 11062-11086.
Crossref
Crossref
Xiaoli Wang, Ning Wang, Ying Yang, Xiaoxiao Wang, Jiayi Liang, Xinxin Tian, Hailing Zhang & Xigang Leng. (2019) Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomaterials Science 7:7, pages 3062-3075.
Crossref
Crossref
Carlo Gabriele TocchettiChristian CadedduDaniela Di LisiSaveria FemminòRosalinda MadonnaDonato MeleInes MonteGiuseppina NovoClaudia PennaAlessia PepePaolo SpallarossaGilda VarricchiConcetta ZitoPasquale PagliaroGiuseppe Mercuro. (2019) From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview. Antioxidants & Redox Signaling 30:18, pages 2110-2153.
Crossref
Crossref
Annika Hirn Lopez, Diana Deen, Zuzanna Fischer, Alexander Rabe, Christian Ansprenger, Kathy Stein, Valentin Vogt, Julia Schick, Tanja Kroell, Doris Kraemer, Hans-Jochem Kolb, Johanna Tischer, Christoph Schmid & Helga Schmetzer. (2019) Role of Interferon (IFN)α in “Cocktails” for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions. Journal of Immunotherapy 42:5, pages 143-161.
Crossref
Crossref
Robert A. Belderbos, Joachim G.J.V. Aerts & Heleen Vroman. (2019) Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment. Molecular Therapy - Oncolytics 13, pages 67-81.
Crossref
Crossref
Tamaki Yahata, Mika Mizoguchi, Akihiko Kimura, Takashi Orimo, Saori Toujima, Yumi Kuninaka, Mizuho Nosaka, Yuko Ishida, Izumi Sasaki, Yuri Fukuda‐Ohta, Hiroaki Hemmi, Naoyuki Iwahashi, Tomoko Noguchi, Tsuneyasu Kaisho, Toshikazu Kondo & Kazuhiko Ino. (2019)
Programmed cell death ligand 1
d
isruption by
clustered regularly interspaced short palindromic repeats
/Cas9‐genome editing promotes antitumor immunity and suppresses ovarian cancer progression
. Cancer Science 110:4, pages 1279-1292.
Crossref
Crossref
Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqin Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu & Baohui Han. (2019) Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy. European Respiratory Journal 53:3, pages 1801562.
Crossref
Crossref
Amirhossein Bahreyni, Elnaz Ghorbani, Hamid Fuji, Mikhail Ryzhikov, Majid Khazaei, Marjan Erfani, Amir Avan, Seyed M. Hassanian & Kayhan Azadmanesh. (2018) Therapeutic potency of oncolytic virotherapy–induced cancer stem cells targeting in brain tumors, current status, and perspectives. Journal of Cellular Biochemistry 120:3, pages 2766-2773.
Crossref
Crossref
Pallavi Jain, Pier-Luc Clermont, Francis Desmeules, Amina Zoubeidi, Bertrand Neveu & Frédéric Pouliot. (2019) Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer Cells. International Journal of Molecular Sciences 20:1, pages 216.
Crossref
Crossref
Samaneh Arab & Jamshid Hadjati. (2019) Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy. Immune Network 19:4.
Crossref
Crossref
Sermin Tetik & Nilgun Tekkesin. 2019. Theranostic Approach for Pancreatic Cancer. Theranostic Approach for Pancreatic Cancer
97
110
.
Pradip Kumar Jaiswara, Vishal Kumar Gupta, Shiv Govind Rawat, Pratishtha Sonker & Ajay Kumar. 2019. Phytochemistry: An in-silico and in-vitro Update. Phytochemistry: An in-silico and in-vitro Update
69
82
.
Steven J. Conrad & Jia Liu. 2019. Viral Vectors for Gene Therapy. Viral Vectors for Gene Therapy
189
209
.
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
B. Vincenzi, A. Russo, A. Terenzio, A. Galvano, D. Santini, F. Vorini, R. Antonelli-Incalzi, U. Vespasiani-Gentilucci & G. Tonini. (2018) The use of SAMe in chemotherapy-induced liver injury. Critical Reviews in Oncology/Hematology 130, pages 70-77.
Crossref
Crossref
Michalis Mastri, Christina R. Lee, Amanda Tracz, Robert S. Kerbel, Melissa Dolan, Yuhao Shi & John M.L. Ebos. (2018) Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint Inhibitors. Molecular Cancer Therapeutics 17:7, pages 1602-1612.
Crossref
Crossref
Daqing Wang, Wayne Jiang, Fugang Zhu, Xianzhi Mao & Sudhir Agrawal. (2018) Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy. International Journal of Oncology.
Crossref
Crossref
Lei Li, Hong Yang, Yan Li, Xiao-Dong Li, Ting-Ting Zeng, Su-Xia Lin, Ying-Hui Zhu & Xin-Yuan Guan. (2018) Hypoxia restrains the expression of complement component 9 in tumor-associated macrophages promoting non-small cell lung cancer progression. Cell Death Discovery 4:1.
Crossref
Crossref
Charbel Darido, Smitha R. Georgy, Carleen Cullinane, Darren D. Partridge, Rachael Walker, Seema Srivastava, Suraya Roslan, Marina R. Carpinelli, Sebastian Dworkin, Richard B. Pearson & Stephen M. Jane. (2017) Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin. Cell Death & Differentiation 25:6, pages 1146-1159.
Crossref
Crossref
Gauravi Raut & Sarika Wairkar. (2018) Management of psoriasis with nutraceuticals: An update. Complementary Therapies in Clinical Practice 31, pages 25-30.
Crossref
Crossref
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Crossref
Nataša Obermajer, Julie Urban, Eva Wieckowski, Ravikumar Muthuswamy, Roshni Ravindranathan, David L Bartlett & Pawel Kalinski. (2018) Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nature Protocols 13:2, pages 335-357.
Crossref
Crossref
Si-Rui Ma, Wei-Wei Deng, Jian-Feng Liu, Liang Mao, Guang-Tao Yu, Lin-Lin Bu, Ashok B. Kulkarni, Wen-Feng Zhang & Zhi-Jun Sun. (2017) Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma. Molecular Cancer 16:1.
Crossref
Crossref
Y Sunakawa, S Cao, N B Volz, M D Berger, D Yang, A Parekh, W Zhang, S Matsusaka, Y Ning, S Stremitzer, S Stintzing, A Sebio, S Okazaki, T Wakatsuki, M Azuma, M Watanabe, W Koizumi, A H Wu & H-J Lenz. (2016) Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. The Pharmacogenomics Journal 17:6, pages 528-534.
Crossref
Crossref
Merilin Al Sharif, Petko Alov, Vessela Vitcheva, Antonia Diukendjieva, Mattia Mori, Bruno Botta, Ivanka Tsakovska & Ilza Pajeva. (2017) Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction. Toxicology and Applied Pharmacology 337, pages 45-66.
Crossref
Crossref
Guangbao Yang, Ligeng Xu, Yu Chao, Jun Xu, Xiaoqi Sun, Yifan Wu, Rui Peng & Zhuang Liu. (2017) Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nature Communications 8:1.
Crossref
Crossref
Tomohiro Tanaka, Satoshi Watanabe, Miho Takahashi, Ko Sato, Yu Saida, Junko Baba, Masashi Arita, Miyuki Sato, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Nobumasa Aoki, Yasuyoshi Ohshima, Takuro Sakagami, Tetsuya Abe, Hiroshi Moro, Toshiyuki Koya, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa & Toshiaki Kikuchi. (2017) Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells. PLOS ONE 12:8, pages e0183976.
Crossref
Crossref
Brad Bolon & Famke Aeffner. (2017) A Primer for Oncoimmunology (Immunooncology). Toxicologic Pathology 45:5, pages 584-588.
Crossref
Crossref
Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, Paul A. Beavis, Jennifer A. Westwood, Sherly Mardiana, David C. Tscharke, Sarah Ellis, H. Miles Prince, Joseph A. Trapani, Ricky W. Johnstone, Mark J. Smyth, Michele W. Teng, Aesha Ali, Zhiya Yu, Steven A. Rosenberg, Nicholas P. Restifo, Paul Neeson, Phillip K. Darcy & Michael H. Kershaw. (2017) Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clinical Cancer Research 23:10, pages 2478-2490.
Crossref
Crossref
Kristine De La Torre, Elly Cohen, Anne Loeser & Marc Hurlbert. (2017) Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses. npj Breast Cancer 3:1.
Crossref
Crossref
Ursa Lampreht Tratar, Luisa Loiacono, Maja Cemazar, Urska Kamensek, Vito Michele Fazio, Gregor Sersa & Emanuela Signori. (2017) Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma. Mediators of Inflammation 2017, pages 1-11.
Crossref
Crossref
Meirong Huo, Yan Zhao, Andrew Benson Satterlee, Yuhua Wang, Ying Xu & Leaf Huang. (2017) Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. Journal of Controlled Release 245, pages 81-94.
Crossref
Crossref
M.A. Hayat. 2017. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
1
122
.
Timothy Frankel, Mirna Perusina Lanfranca & Weiping Zou. 2017. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy
51
64
.
Yu-Ting Cheng, Chun-Chih Yang & Lie-Fen Shyur. (2016) Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy. Pharmacological Research 114, pages 128-143.
Crossref
Crossref
Qiu Xia, Fang-Fang Zhang, Fei Geng, Chen-Lu Liu, Yu-Qian Wang, Ping Xu, Zhen-Zhen Lu, Yu Xie, Hui Wu, Yan Chen, Yong Zhang, Wei Kong, Xiang-Hui Yu & Hai-Hong Zhang. (2016) Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer. Cellular Immunology 310, pages 89-98.
Crossref
Crossref
Ahmed Z. Gad, Shahenda El-Naggar & Nabil Ahmed. (2016) Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy 18:11, pages 1382-1392.
Crossref
Crossref
Lukasz Kuryk, Elina Haavisto, Mariangela Garofalo, Cristian Capasso, Mari Hirvinen, Sari Pesonen, Tuuli Ranki, Lotta Vassilev & Vincenzo Cerullo. (2016) Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model. International Journal of Cancer 139:8, pages 1883-1893.
Crossref
Crossref
Maria-Luisa SchubertAngela HückelhovenJean-Marc HoffmannAnita SchmittPatrick WuchterLeopold SellnerSusanne HofmannAnthony D. HoPeter DregerMichael Schmitt. (2016) Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation. Human Gene Therapy 27:10, pages 758-771.
Crossref
Crossref
Sophie Cousin & Antoine Italiano. (2016) Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities. Clinical Cancer Research 22:18, pages 4550-4555.
Crossref
Crossref
Qiu Xia, Fei Geng, Fang-Fang Zhang, Chen-Lu Liu, Ping Xu, Zhen-Zhen Lu, Hai-Hong Zhang, Wei Kong & Xiang-Hui Yu. (2016) Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice. Vaccine 34:38, pages 4526-4535.
Crossref
Crossref
Laure Aurelian, Dominique Bollino & Aric Colunga. (2016) The oncolytic virus ΔPK has multimodal anti-tumor activity. Pathogens and Disease 74:5, pages ftw050.
Crossref
Crossref
Kimberly Loo & Adil Daud. (2016) Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma. Immunotherapy 8:7, pages 775-784.
Crossref
Crossref
Aurélie Hanoteau, Coralie Henin & Muriel Moser. (2016) L’immunothérapie au service de la chimiothérapie, de nouvelles avancées. médecine/sciences 32:4, pages 353-361.
Crossref
Crossref
Dominique Bollino, Aric Colunga, Baiquan Li & Laure Aurelian. (2016) ΔPK oncolytic activity includes modulation of the tumour cell milieu. Journal of General Virology 97:2, pages 496-508.
Crossref
Crossref
J.M. Michot, C. Bigenwald, S. Champiat, M. Collins, F. Carbonnel, S. Postel-Vinay, A. Berdelou, A. Varga, R. Bahleda, A. Hollebecque, C. Massard, A. Fuerea, V. Ribrag, A. Gazzah, J.P. Armand, N. Amellal, E. Angevin, N. Noel, C. Boutros, C. Mateus, C. Robert, J.C. Soria, A. Marabelle & O. Lambotte. (2016) Immune-related adverse events with immune checkpoint blockade: a comprehensive review. European Journal of Cancer 54, pages 139-148.
Crossref
Crossref
Mari Hirvinen, Cristian Capasso, Kilian Guse, Mariangela Garofalo, Andrea Vitale, Marko Ahonen, Lukasz Kuryk, Markus Vähä-Koskela, Akseli Hemminki, Vittorio Fortino, Dario Greco & Vincenzo Cerullo. (2016) Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Molecular Therapy - Oncolytics 3, pages 16002.
Crossref
Crossref
João Conde, Christina E. Arnold, Furong Tian & Natalie Artzi. (2016) RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?. Materials Today 19:1, pages 29-43.
Crossref
Crossref
Haidong Tang, Jian Qiao & Yang-Xin Fu. (2016) Immunotherapy and tumor microenvironment. Cancer Letters 370:1, pages 85-90.
Crossref
Crossref
Grégory Verdeil, Silvia A. Fuertes Marraco, Timothy Murray & Daniel E. Speiser. (2016) From T cell “exhaustion” to anti-cancer immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:1, pages 49-57.
Crossref
Crossref
R. King & C. Tuthill. 2016. Thymosins. Thymosins
151
178
.
Lauren V. Albrecht, Kathleen J. Green & Adi D. Dubash. 2016. The Cadherin Superfamily. The Cadherin Superfamily
363
397
.
Thomas J. Cradick. 2016. Novel Immunotherapeutic Approaches to the Treatment of Cancer. Novel Immunotherapeutic Approaches to the Treatment of Cancer
203
247
.
Vera Kemp, Rob Hoeben & Diana van den Wollenberg. (2015) Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus. Viruses 8:1, pages 4.
Crossref
Crossref
Yan Zhao, Meirong Huo, Zhenghong Xu, Yuhua Wang & Leaf Huang. (2015) Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma. Biomaterials 68, pages 54-66.
Crossref
Crossref
Heba Samaha, Shahenda El Naggar & Nabil Ahmed. (2015) Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma. Immunotherapy 7:5, pages 481-485.
Crossref
Crossref
Daniel V.T. Catenacci. (2015) Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity. Molecular Oncology 9:5, pages 967-996.
Crossref
Crossref
Chizuru Ogi & Atsushi Aruga. (2015) Approaches to improve development methods for therapeutic cancer vaccines. Immunology Letters 164:2, pages 100-108.
Crossref
Crossref
Neal Dharmadhikari, Janice M. Mehnert & Howard L. Kaufman. (2015) Oncolytic Virus Immunotherapy for Melanoma. Current Treatment Options in Oncology 16:3.
Crossref
Crossref
Samuel T Workenhe, Meghan L Verschoor & Karen L Mossman. (2015) The role of oncolytic virus immunotherapies to subvert cancer immune evasion. Future Oncology 11:4, pages 675-689.
Crossref
Crossref
J. Wang, T. R. McGuire, H. C. Britton, J. K. Schwarz, F. R. LoberizaJr.Jr., J. L. Meza & J. E. Talmadge. (2015) Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer. Clinical & Experimental Metastasis 32:2, pages 111-124.
Crossref
Crossref
Linh T. Nguyen & Pamela S. Ohashi. (2014) Clinical blockade of PD1 and LAG3 — potential mechanisms of action. Nature Reviews Immunology 15:1, pages 45-56.
Crossref
Crossref
Fnu Apoorva & Ankur Singh. 2015. Biomaterials in Regenerative Medicine and the Immune System. Biomaterials in Regenerative Medicine and the Immune System
171
192
.
Sherven Sharma, Siwen Hu-Lieskovan, Steven M. Dubinett & Jay Moon Lee. 2015. Inflammation and Lung Cancer. Inflammation and Lung Cancer
191
209
.
C Oelkrug & J M Ramage. (2014) Enhancement of T cell recruitment and infiltration into tumours. Clinical and Experimental Immunology 178:1, pages 1-8.
Crossref
Crossref
KEZHI LIN, RUANMIN ZOU, FENG LIN, SHUANG ZHENG, XIAN SHEN & XIANGYANG XUE. (2014) Expression and effect of CXCL14 in colorectal carcinoma. Molecular Medicine Reports 10:3, pages 1561-1568.
Crossref
Crossref
Zhuo-peng Ye, Hai-yong He, Hui Wang, Wen-sheng Li, Lun Luo, Zhen-chao Huang & Ying Guo. (2014) Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells. PLoS ONE 9:8, pages e105350.
Crossref
Crossref
Dongdong Wu, Yanfeng Gao, Yuanming Qi, Lixiang Chen, Yuanfang Ma & Yanzhang Li. (2014) Peptide-based cancer therapy: Opportunity and challenge. Cancer Letters 351:1, pages 13-22.
Crossref
Crossref
Xuqi Li, Pei Li, Yuanhong Chang, Qinhong Xu, Zheng Wu, Qingyong Ma & Zheng Wang. (2014) The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma. Molecular and Cellular Biochemistry 392:1-2, pages 77-84.
Crossref
Crossref
Tracey Baas. (2014) Keys to the CAR. Science-Business eXchange 7:25.
Crossref
Crossref
Andrew Nguyen, Louisa Ho & Yonghong Wan. (2014) Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Richard A Morgan. (2014) Boolean Immunotherapy: Reversal of Fortune. Molecular Therapy 22:6, pages 1073-1074.
Crossref
Crossref
Stephanie C. Casey, Yulin Li & Dean W. Felsher. (2014) An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation. Immunologic Research 58:2-3, pages 282-291.
Crossref
Crossref
Zhenghong Xu, Yuhua Wang, Lu Zhang & Leaf Huang. (2014) Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment. ACS Nano 8:4, pages 3636-3645.
Crossref
Crossref
Verena Raker & Kerstin Steinbrink. (2014) Research in practice: The impact of interferon-? therapy on immune tolerance. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 12:4, pages 315-319.
Crossref
Crossref
Kriti Mittal, John Ebos & Brian Rini. (2014) Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond. Seminars in Oncology 41:2, pages 235-251.
Crossref
Crossref
Atsutaka Minagawa & Shin Kaneko. (2014) Rise of iPSCs as a cell source for adoptive immunotherapy. Human Cell 27:2, pages 47-50.
Crossref
Crossref
Dmitriy Zamarin & Jedd D Wolchok. (2014) Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer. Molecular Therapy - Oncolytics 1, pages 14004.
Crossref
Crossref